Cambridge Investment Research Advisors
AXGN icon

Cambridge Investment Research Advisors’s Axogen AXGN Stock Holding History

Cambridge Investment Research Advisors’s Portfolio AXGN Stock Details AXGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$358K Buy
10,792
+958
+10% +$31.1K ﹤0.01% 3120
2025
Q4 		$322K Buy
+9,834
New +$242K ﹤0.01% 3129

Other funds holding AXGN

FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Cambridge Investment Research Advisors's AXGN Position: Q1 2026 in Review

Cambridge Investment Research Advisors increased its Axogen (AXGN) stake by 9.7% in Q1 2026, buying an estimated $31.1K and bringing the position to 10,792 shares worth $358K. The position accounts for ﹤0.01% of the portfolio, ranked #3120.

Cambridge Investment Research Advisors first reported a position in AXGN in Q4 2025 and has held it in 2 quarters since. 220 funds tracked by Wall St. Rank hold AXGN as of Q1 2026.

  • Cambridge Investment Research Advisors held 10,792 shares of Axogen worth $358K as of Q1 2026.
  • Cambridge Investment Research Advisors bought 958 Axogen shares in Q1 2026, an estimated $31.1K.
  • Axogen made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q1 2026, its #3120 holding.
  • Cambridge Investment Research Advisors first reported a position in Axogen in Q4 2025 and has held it in 2 quarters since.
  • 220 funds tracked by Wall St. Rank held Axogen as of Q1 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.